Cargando…

Non-steroidal anti-inflammatory drugs among chronic kidney disease patients: an epidemiological study

BACKGROUND: Non-steroidal anti-inflammatory drugs (NSAIDs) should be avoided among chronic kidney disease (CKD) patients. Till now, limited data are available on NSAID use in Egypt, and we aimed to study the prevalence and pattern of NSAID use among CKD patients. METHODS: A cross-sectional study was...

Descripción completa

Detalles Bibliográficos
Autores principales: Abd ElHafeez, Samar, Hegazy, Reem, Naga, Yasmine, Wahdan, Iman, Sallam, Sunny
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353805/
https://www.ncbi.nlm.nih.gov/pubmed/30799879
http://dx.doi.org/10.1186/s42506-018-0005-2
_version_ 1783391030742089728
author Abd ElHafeez, Samar
Hegazy, Reem
Naga, Yasmine
Wahdan, Iman
Sallam, Sunny
author_facet Abd ElHafeez, Samar
Hegazy, Reem
Naga, Yasmine
Wahdan, Iman
Sallam, Sunny
author_sort Abd ElHafeez, Samar
collection PubMed
description BACKGROUND: Non-steroidal anti-inflammatory drugs (NSAIDs) should be avoided among chronic kidney disease (CKD) patients. Till now, limited data are available on NSAID use in Egypt, and we aimed to study the prevalence and pattern of NSAID use among CKD patients. METHODS: A cross-sectional study was done among 350 CKD adult patients presented to the Main Alexandria University Hospital. Those with end-stage renal disease and diagnosed with acute renal injury and pregnant women were excluded. Demographic and clinical data were collected by interviewing eligible patients. Data about the pattern, history of drug-drug interactions, and knowledge about the NSAID side effects were also gathered. RESULTS: Of the enrolled patients, 57.1% were hypertensive, 46% were diabetics, 28% had osteoarthritis, and 18.3% had cardiovascular disease. CKD stages were 3.7%, 40.3%, and 56% in stages 2, 3, and 4, respectively. Almost two thirds (65.7%) were NSAID users. Among them, 82.6% were regular users. Headache was the most reported (68.7%) reason of use. The use of drugs which may have drug-drug interaction with the NSAIDs (as diuretics or renin-angiotensin-aldosterone system inhibitors) was reported in 36%. In multiple logistic regression, the odds of NSAID use decreased by 4% (odds ratio (OR) = 0.96, 95% confidence interval (CI) 0.93–0.99, p = 0.01) for every year increase in the patient’s age and decreased by 3% (OR = 0.97, 95% CI 0.95–0.99, p = 0.01) for every 1 ml/min/1.73 m(2) increase in glomerular filtration rate. CONCLUSION: Despite the hazards of NSAID use on the kidney, still high proportion of CKD patients are using them for a long period and they are simultaneously using other drugs with possible drug-drug interactions. This study provided important information that would decrease the gap in knowledge about the use of NSAID in Egypt. It is recommended that NSAIDs should be used with caution among CKD patients and patients should be advised about its adverse health consequences.
format Online
Article
Text
id pubmed-6353805
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-63538052019-02-21 Non-steroidal anti-inflammatory drugs among chronic kidney disease patients: an epidemiological study Abd ElHafeez, Samar Hegazy, Reem Naga, Yasmine Wahdan, Iman Sallam, Sunny J Egypt Public Health Assoc Research BACKGROUND: Non-steroidal anti-inflammatory drugs (NSAIDs) should be avoided among chronic kidney disease (CKD) patients. Till now, limited data are available on NSAID use in Egypt, and we aimed to study the prevalence and pattern of NSAID use among CKD patients. METHODS: A cross-sectional study was done among 350 CKD adult patients presented to the Main Alexandria University Hospital. Those with end-stage renal disease and diagnosed with acute renal injury and pregnant women were excluded. Demographic and clinical data were collected by interviewing eligible patients. Data about the pattern, history of drug-drug interactions, and knowledge about the NSAID side effects were also gathered. RESULTS: Of the enrolled patients, 57.1% were hypertensive, 46% were diabetics, 28% had osteoarthritis, and 18.3% had cardiovascular disease. CKD stages were 3.7%, 40.3%, and 56% in stages 2, 3, and 4, respectively. Almost two thirds (65.7%) were NSAID users. Among them, 82.6% were regular users. Headache was the most reported (68.7%) reason of use. The use of drugs which may have drug-drug interaction with the NSAIDs (as diuretics or renin-angiotensin-aldosterone system inhibitors) was reported in 36%. In multiple logistic regression, the odds of NSAID use decreased by 4% (odds ratio (OR) = 0.96, 95% confidence interval (CI) 0.93–0.99, p = 0.01) for every year increase in the patient’s age and decreased by 3% (OR = 0.97, 95% CI 0.95–0.99, p = 0.01) for every 1 ml/min/1.73 m(2) increase in glomerular filtration rate. CONCLUSION: Despite the hazards of NSAID use on the kidney, still high proportion of CKD patients are using them for a long period and they are simultaneously using other drugs with possible drug-drug interactions. This study provided important information that would decrease the gap in knowledge about the use of NSAID in Egypt. It is recommended that NSAIDs should be used with caution among CKD patients and patients should be advised about its adverse health consequences. Springer Berlin Heidelberg 2019-01-30 /pmc/articles/PMC6353805/ /pubmed/30799879 http://dx.doi.org/10.1186/s42506-018-0005-2 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Research
Abd ElHafeez, Samar
Hegazy, Reem
Naga, Yasmine
Wahdan, Iman
Sallam, Sunny
Non-steroidal anti-inflammatory drugs among chronic kidney disease patients: an epidemiological study
title Non-steroidal anti-inflammatory drugs among chronic kidney disease patients: an epidemiological study
title_full Non-steroidal anti-inflammatory drugs among chronic kidney disease patients: an epidemiological study
title_fullStr Non-steroidal anti-inflammatory drugs among chronic kidney disease patients: an epidemiological study
title_full_unstemmed Non-steroidal anti-inflammatory drugs among chronic kidney disease patients: an epidemiological study
title_short Non-steroidal anti-inflammatory drugs among chronic kidney disease patients: an epidemiological study
title_sort non-steroidal anti-inflammatory drugs among chronic kidney disease patients: an epidemiological study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353805/
https://www.ncbi.nlm.nih.gov/pubmed/30799879
http://dx.doi.org/10.1186/s42506-018-0005-2
work_keys_str_mv AT abdelhafeezsamar nonsteroidalantiinflammatorydrugsamongchronickidneydiseasepatientsanepidemiologicalstudy
AT hegazyreem nonsteroidalantiinflammatorydrugsamongchronickidneydiseasepatientsanepidemiologicalstudy
AT nagayasmine nonsteroidalantiinflammatorydrugsamongchronickidneydiseasepatientsanepidemiologicalstudy
AT wahdaniman nonsteroidalantiinflammatorydrugsamongchronickidneydiseasepatientsanepidemiologicalstudy
AT sallamsunny nonsteroidalantiinflammatorydrugsamongchronickidneydiseasepatientsanepidemiologicalstudy